GENIX success in the inland market has encouraged us to challenge the international arena. Genix, a leading & fast growing Pharmaceutical manufacturer in Pakistan, continues its voyage towards inherent dream to become a key contributor in the world Pharmaceutical market by maintaining a constant commitment to research, developing innovative products and quality management. Our unwavering determination to achieve excellence leads us to new global benchmarks.
Genix is guided by its export mission to improve the health and well-being of people worldwide. Its corporate philosophy is to create new value around health-related products through science and advanced technology.
We have always given high priority to its Research and Development activities. We will continue with our quest to introduce new and technologically advanced molecules and innovative dosage forms. These molecules and dosage forms have played key role towards the rapid growth of the company in the last decade.
The company is dedicating a significant percentage of its resources to strengthening its technology including biotechnology, centered on Pharmaceuticals. In order to expand its bio-tech business abroad Genix has already established a state-of-the-art Bio-tech facility which will go into production soon.
Within five years of starting export operations, Genix exports its products in more than 20 countries. This has become possible due to an intellectual pool of some of the best minds in the country. Starting in 2006, Genix already has registration of more than 150 products in different countries around the globe. Further negotiation with possible business partners and product registration is going on to augment the presence of the company in more countries.
With Dynamics and constantly evolving, Genix aims to emerge is a key player in the global pharmaceutical industry by providing its customers worldwide with accessible, high quality and advanced healthcare solutions.
Copyright © Genix Pharma Private Limited, all rights are reserved.
Global Operations
We are moving aggressively to increase its market share
in the operating countries as well as to move to new countries.